November 22, 2016

‘Brighter Than A Billion Suns’: SLAC Studies Featured in TEDx Talk

Paleontologist Phil Manning describes the “Imaging Life on Earth” project at TEDxCharleston.

Video

Phil Manning and his colleagues have used synchrotron light for nearly a decade to help interpret the chemical signatures locked within fossilized life. Bright X-rays have allowed them to study fossilized worm burrows, recreate pigment patterns in ancient bird feathers, see how Jurassic dinosaur bones heal and image the living chemistry of 50-million year old plant fossils.

Manning, a professor of paleontology at the College of Charleston and professor of natural history at the University of Manchester, recently spoke about these efforts during his talk “Brighter Than A Billion Suns: Imaging Life On Earth” at a TEDx event in Charleston, South Carolina on Oct. 19.

He collaborates with Uwe Bergmann, physicist at the Department of Energy’s SLAC National Accelerator Laboratory, and Roy Wogelius, professor of geochemistry at the University of Manchester, to apply synchrotron rapid scanning X-ray fluorescence to iconic fossil specimens. These imaging experiments take place at the Stanford Synchrotron Radiation Lightsource (SSRL) at SLAC, as well as the Diamond Light Source in the United Kingdom. SSRL is a DOE Office of Science User Facility.


SLAC is a multi-program laboratory exploring frontier questions in photon science, astrophysics, particle physics and accelerator research. Located in Menlo Park, Calif., SLAC is operated by Stanford University for the U.S. Department of Energy's Office of Science.

SLAC National Accelerator Laboratory is supported by the Office of Science of the U.S. Department of Energy. The Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit science.energy.gov.

Phil Manning, professor of paleontology at the College of Charleston in South Carolina and professor of natural history at the University of Manchester in the United Kingdom, presents his research team's work at TEDxCharleston on October 19, 2016. (TEDxCharleston)
Dig Deeper

Related stories

News Feature

Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer...

Three people in lab coats examine chemistry equipment.
News Feature

Disabling those hinges could be a good strategy for designing vaccines and treatments against a broad range of coronavirus infections.

A 3D image of a round, spiky coronavirus with inset showing how far its spikes can bend.
News Feature

A   swap of metals and a mutation ramp up the electric field strength at the active site of an enzyme, making it  ...

Illustration of an enzyme modified to work 50 times faster
News Feature

Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer...

Three people in lab coats examine chemistry equipment.
News Feature

Disabling those hinges could be a good strategy for designing vaccines and treatments against a broad range of coronavirus infections.

A 3D image of a round, spiky coronavirus with inset showing how far its spikes can bend.
News Feature

A   swap of metals and a mutation ramp up the electric field strength at the active site of an enzyme, making it  ...

Illustration of an enzyme modified to work 50 times faster
News Feature

Developing a new, light-activated method to produce the molecule opens doors for future biomedical applications.

An illustration of an X-ray spectroscopy experiment.
News Feature

An international team has uncovered details about the formation of DNA's building blocks, paving the way  for potential medical and therapeutic applications.

radical
News Feature

Scientists developed a new method to unlock the secrets of RNA. The implications are wide-reaching, from better understanding diseases to designing new therapeutics. 

CXI hutch